Intermittent intravenous administration of Iloprost in patients with idiopathic pulmonary arterial hypertension

Intermittent IV administration of Iloprost decreases the FC, PAPm, RVP, and serum level of NT-proBNP and increases the distance walked in the 6MWT by patients.